India a leading global power, says new US security policy

Agencies
December 19, 2017

Washington, Dec 19: Describing India as a "leading global power", the US today unveiled its new National Security Strategy (NSS) that said it will "deepen" America's strategic partnership with India and support its leadership role in Indian Ocean security and throughout the broader region.

With an eye on China's One Belt One Road (OBOR) and the China-Pakistan Economic Corridor (CPEC), the US administration said it will help South Asian countries "maintain their sovereignty" as China increases its influence in the region.

The NSS also seeks Pakistan to take decisive action against terrorists.

"We welcome India's emergence as a leading global power and stronger strategic and defence partner," said the National Security Strategy unveiled by President Donald Trump.

The 68-page document said the US will seek to increase quadrilateral cooperation with Japan, Australia, and India.

"We will expand our defence and security cooperation with India, a Major Defence Partner of the United States, and support India's growing relationships throughout the region," the NSS said, noting that its vision for Indo-Pacific excludes no nation.

India-US defence relationship was mentioned in the context of Indo-Pacific region, whereas it gave a very prominent role to India in South and Central Asia.

"We will deepen our strategic partnership with India and support its leadership role in Indian Ocean security and throughout the broader region," according to the NSS which the White House said sets a positive strategic direction for the US that will restore America's advantages in the world and build upon our country's great strengths.

The NSS said it will press Pakistan to intensify its counter-terrorism efforts, since no partnership can survive a country's support for militants and terrorists who target a partner's own service members and officials.

"The United States will also encourage Pakistan to continue demonstrating that it is a responsible steward of its nuclear assets," it said adding the US will continue to partner with Afghanistan to promote peace and security in the region.

In an apparent reference to the OBOR and CPEC, the NSS said, "We will help South Asian nations maintain their sovereignty as China increases its influence in the region".

The recent Chinese move in Sri Lanka and Maldives is seen as an effort on their part to encroach eat on their sovereignty with similar fears in Pakistan.

India has objected to CPEC as it passes through Pakistan-occupied Kashmir.

The US, it said, continues to face threats from transnational terrorists and militants operating from within Pakistan.

"The prospect for an Indo-Pakistani military conflict that could lead to a nuclear exchange remains a key concern requiring consistent diplomatic attention," NSS said.

US interests in the region include countering terrorist threats that impact the security of the US homeland and its allies, preventing cross-border terrorism that raises the prospect of military and nuclear tensions, and preventing nuclear weapons, technology, and materials from falling into the hands of terrorists, it said.

"We seek an American presence in the region proportionate to threats to the homeland and our allies. We seek a Pakistan that is not engaged in destabilising behaviour and a stable and self-reliant Afghanistan," the NSS said.

Insisting that it is committed to supporting the Afghan government and security forces in their fight against the Taliban, al-Qaeda, ISIS, and other terrorists, the NSS said the US will bolster the fighting strength of the Afghan security forces to convince the Taliban that they cannot win on the battlefield and to set conditions for diplomatic efforts to achieve enduring peace.

"We will insist that Pakistan take decisive action against militant and terrorist groups operating from its soil," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 23,2020

Karachi, May 23: Ninety-seven people were killed and two survived when a passenger plane crashed into homes in Pakistan's southern city of Karachi, health officials said Saturday.

The Pakistan International Airlines (PIA) plane had made multiple approaches to land at the city's airport when it came down in a residential area, damaging buildings and sparking a rescue operation that lasted into the night.

All passengers and crew had been accounted for and the bodies of those killed had been recovered from the crash site, the Sindh Health Ministry said, adding that 19 had been identified.

A local hospital earlier reported it had received the bodies of people killed on the ground.

The site remained cordoned off on Saturday morning.

The crash sent plumes of smoke were into the air as rescue workers and residents searched the debris for people and as firefighters tried to extinguish the flames.

An AFP reporter witnessed charred bodies being loaded into ambulances.

PIA said the plane lost contact with air traffic control just after 2:30 pm (0930 GMT) travelling from Lahore to Karachi.

The disaster comes as Pakistanis prepare to celebrate the end of Ramadan and the beginning of Eid al-Fitr, with many travelling back to their homes in cities and villages.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 24,2020

Kuala Lumpur, Feb 24: Malaysian Prime Minister Mahathir Mohamad has submitted his resignation to the king, two sources with direct knowledge of the matter told Reuters on Monday, amid talks of forming a new coalition to govern the country.

Mahathir, 94, assumed office in May 2018 for his second stint as prime minister.

A spokesman from the prime minister's office declined to comment, saying only that a statement will be issued soon.

The sources declined to be named as they were not authorised to talk to the media.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.